Both in Lab Analytical Instruments
Nautilus Biotechnolgy vs Harvard Bioscience
Over the past year NAUT returned +44.0% and HBIO returned +39.7%; their daily moves had a correlation of 0.02.
NAUT +44.0% HBIO +39.7%Growth of $1, one year, split-adjusted
| Metric | NAUT | HBIO |
|---|---|---|
| Price | $2.29 | $8.61 |
| Market cap | $291.7M | $39.2M |
| Today | −2.55% | −0.69% |
| 1 month | +29.4% | +0.6% |
| 6 months | −22.1% | +18.9% |
| Year to date | +17.4% | +28.7% |
| 1 year | +23.8% | +50.0% |
| Revenue growth (YoY) | — | +11.1% |
| Gross margin | 89.7% | 55.6% |
| Net margin | −6682.1% | −12.8% |
| P/E (TTM) | — | — |
| Price / sales | 687.9× | 0.4× |
| Net cash | $86.6M | -$30.2M |
| Dividend yield | — | — |
| Volatility (60d) | 156.2% | 35.1% |
| Short % of float | 10.4% | 1.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).